Enzo Biochem, Inc. (ENZ) Misses Q1 Views

December 12, 2011 4:16 PM EST Send to a Friend
Enzo Biochem, Inc. (NYSE: ENZ) reported Q1 EPS of ($0.12), $0.04 worse than the analyst estimate of ($0.08). Revenue for the quarter came in at $25.75 million versus the consensus estimate of $27.04 million.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Add Your Comment